Skip to content

Transvaginal middle-urethral linear suspension in the treatment of stress urinary incontinence

Transvaginal middle-urethral linear suspension in the treatment of stress urinary incontinence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097268
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stress urinary incontinence

Interventions

experimental group:transvaginal middle-urethral linear suspension
conventional surgery group:Anterior vaginal wall repair surgery

Sponsors

Changzhou NO.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with symptomatic stress incontinence, including urgency to urinate, frequency of urination, urinary retention, and urinary incontinence, were identified as patients with uncomplicated stress incontinence by urodynamic determination. 2.The POP-Q stage III and above, mainly pelvic organ prolapse, accompanied by stress incontinence, was determined to be uncomplicated stress incontinence by urine flow mechanics, and the patient was treated for POP for the first time.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications of laparoscopic surgery, such as heart, brain, liver and renal dysfunction can not tolerate surgery and mental dysfunction can not cooperate. 2. Patients with a history of silk knot rejection. 3. Excluding patients with pelvic inflammatory disease and confirmed or strongly suspected substantial adhesion between the sigmoid colon and the anterior sacral peritoneum. 4. Patients suspected of having malignant tumors should be excluded by gynecologic ultrasound, pelvic MRI, cervical cancer screening and tumor indicators. 5. Currently in a pregnant state. 6. Patients who are too old to tolerate surgery or whose surgical benefits are significantly less than the surgical trauma.

Design outcomes

Primary

MeasureTime frame
Operative effect;

Secondary

MeasureTime frame
Pelvic floor diseases and quality of life;Incidence of postoperative complications;Quantitative grading of pelvic organ prolapse;

Countries

China

Contacts

Public ContactPengcheng Jiang

Changzhou NO.2 People's Hospital

13921041128@139.com+86 13921041128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026